Modulation of the activity and arachidonic acid selectivity of group X secretory phospholipase A2 by sphingolipids

Journal of Lipid Research

Volumn 48, Issue 3, 2007, Pages 683-692

  Singh, Dev K ^a   Subbaiah, Papasani V ^a  

^a UNIVERSITY OF ILLINOIS AT CHICAGO   (United States)

Author keywords

Ceramide; Fatty acid; Inflammation; Specificity; Sphingomyelin

Indexed keywords

ARACHIDONIC ACID; CERAMIDE; HIGH DENSITY LIPOPROTEIN; LINOLEIC ACID; PHOSPHATIDYLCHOLINE; PHOSPHOLIPASE A2; SPHINGOLIPID; SPHINGOMYELIN; SPHINGOMYELIN PHOSPHODIESTERASE;

ARTICLE; ENZYME ACTIVITY; ENZYME ASSAY; ENZYME DEGRADATION; ENZYME INHIBITION; LIPID ANALYSIS; PRIORITY JOURNAL;

ANIMALS; ARACHIDONIC ACID; CERAMIDES; CHO CELLS; CRICETINAE; CRICETULUS; FATTY ACIDS; HUMANS; HYDROLYSIS; LIPOPROTEINS, HDL; MACROPHAGES; MICE; PHOSPHOLIPASES A; RECOMBINANT PROTEINS; SPHINGOLIPIDS; SUBSTRATE SPECIFICITY;

EID: 33947189125     PISSN: 00222275     EISSN: 15397262     Source Type: Journal    
DOI: 10.1194/jlr.M600421-JLR200     Document Type: Article

References (52)

1. Simons, K., and D. Toomre. 2000. Lipid rafts and signal transduction. Nat. Rev. Mol. Cell Biol. 1: 31-39.
2. Pike, L. J. 2003. Lipid rafts: bringing order to chaos. J. Lipid Res. 44: 655-667.
3. Wong, M. L., B. Xie, N. Beatini, P. Phu, S. Marathe, A. Johns, P. W. Gold, E. Hirsch, K. J. Williams, J. Licinio, et al. 2000. Acute systemic inflammation up-regulates secretory sphingomyelinase in vivo: a possible link between inflammatory cytokines and atherogenesis. Proc. Natl. Acad. Sci. USA. 97: 8681-8686.
4. Marchesini, N., and Y. A. Hannun. 2004. Acid and neutral sphingomyelinases: roles and mechanisms of regulation. Biochem. Cell Biol. 82: 27-44.
5. Perry, D. K., and Y. A. Hannun. 1998. The role of ceramide in cell signaling. Biochim. Biophys. Acta. 1436: 233-243.
6. Ruvolo, P. P. 2003. Intracellular signal transduction pathways activated by ceramide and its metabolites. Pharmacol. Res. 47: 383-392.
7. Kronke, M. 1999. Biophysics of ceramide signaling: interaction with proteins and phase transition of membranes. Chem. Phys. Lipids. 101: 109-121.
8. Subbaiah, P. V., and M. Liu. 1993. Role of sphingomyelin in the regulation of cholesterol esterification in the plasma lipoproteins. Inhibition of lecithin-cholesterol acyltransferase. J. Biol. Chem. 268: 20156-20163.
9. Bolin, D. J., and A. Jonas. 1996. Sphingomyelin inhibits the lecithincholesterol acyltransferase reaction with reconstituted high density lipoproteins by decreasing enzyme binding. J. Biol. Chem. 271: 19152-19158.
10. Subbaiah, P. V., P. Horvath, and S. B. Achar. 2006. Regulation of the activity and fatty acid specificity of lecithin-cholesterol acyltransferase by sphingomyelin and its metabolites, ceramide and ceramide phosphate. Biochemistry. 45: 5029-5038.
11. Rye, K. A., N. J. Hime, and P. J. Barter. 1996. The influence of sphingomyelin on the structure and function of reconstituted high density lipoproteins. J. Biol. Chem. 271: 4243-4250.
12. 2 by sphingomyelin and annexin VI. Biochem. J. 326: 227-233.
13. 2 in the metabolism of lipoproteins. Substrate specificities of the enzymes and the regulation of their activities by sphingomyelin. Biochemistry. 41: 4911-4920.
14. Klapisz, E., J. Masliah, G. Bereziat, C. Wolf, and K. S. Koumanov. 2000. Sphingolipids and cholesterol modulate membrane susceptibility to cytosolic phospholipase A(2). J. Lipid Res. 41: 1680-1688.
15. Lobo, L. I. B., and D. C. Wilton. 1997. Combined effects of sphingomyelin and cholesterol on the hydrolysis of emulsion particle triolein by lipoprotein lipase. Biochim. Biophys. Acta. 1349: 122-130.
16. Arimoto, I., H. Saito, Y. Kawashima, K. Miyajima, and T. Handa. 1998. Effects of sphingomyelin and cholesterol on lipoprotein lipase-mediated lipolysis in lipid emulsions. J. Lipid Res. 39: 143-151.
17. Subbaiah, P. V., and R. M. Sargis. 2001. Sphingomyelin: a natural modulator of membrane homeostasis and inflammation. Med. Hypotheses. 57: 135-138.
18. Chap, H. J., R. F. A. Zwaal, and L. L. M. van Deenen. 1977. Action of highly purified phospholipases on blood platelets. Evidence for an asymmetric distribution of phospholipids in the surface membrane. Biochim. Biophys. Acta. 467: 146-164.
19. Kudo, I., and M. Murakami. 2002. Phospholipase A2 enzymes. Prostaglandins Other Lipid Mediat. 68-69: 3-58.
20. Nevalainen, T. J., M. M. Haapamaki, and J. M. Gronroos. 2000. Roles of secretory phospholipases A(2) in inflammatory diseases and trauma. Biochim. Biophys. Acta. 1488: 83-90.
21. Tselepis, A. D., and M. J. Chapman. 2002. Inflammation, bioactive lipids and atherosclerosis: potential roles of a lipoprotein-associated phospholipase A2, platelet activating factor-acetylhydrolase. Atheroscler. Suppl. 3: 57-68.
22. Hanasaki, K., T. Ono, A. Saiga, Y. Morioka, M. Ikeda, K. Kawamoto, K. Higashino, K. Nakano, K. Yamada, J. Ishizaki, et al. 1999. Purified group X secretory phospholipase A(2) induced prominent release of arachidonic acid from human myeloid leukemia cells. J. Biol. Chem. 274: 34203-34211.
23. Bezzine, S., R. S. Koduri, E. Valentin, M. Murakami, I. Kudo, F. Ghomashchi, M. Sadilek, G. Lambeau, and M. H. Gelb. 2000. Exogenously added human group X secreted phospholipase A(2) but not the group IB, IIA, and V enzymes efficiently release arachidonic acid from adherent mammalian cells. J. Biol. Chem. 275: 3179-3191.
24. Cho, W. 2000. Structure, function, and regulation of group V phospholipase A(2). Biochim. Biophys. Acta. 1488: 48-58.
25. Murakami, M., S. Shimbara, T. Kambe, H. Kuwata, M. V. Winstead, J. A. Tischfield, and I. Kudo. 1998. The functions of five distinct mammalian phospholipase A2S in regulating arachidonic acid release. Type IIa and type V secretory phospholipase A2S are functionally redundant and act in concert with cytosolic phospholipase A2. J. Biol. Chem. 273: 14411-14423.
26. Pruzanski, W., L. Lambeau, M. Lazdunsky, W. Cho, J. Kopilov, and A. Kuksis. 2005. Differential hydrolysis of molecular species of lipoprotein phosphatidylcholine by groups IIA, V and X secretory phospholipases A2. Biochim. Biophys. Acta. 1736: 38-50.
27. Subbaiah, P. V., S. J. Billington, B. H. Jost, J. G. Songer, and Y. Lange. 2003. Sphingomyelinase D, a novel probe for cellular sphingomyelin: effects on cholesterol homeostasis in human skin fibroblasts. J. Lipid Res. 44: 1574-1580.
28. Subbaiah, P. V., M. Liu, P. J. Bolan, and F. Paltauf. 1992. Altered positional specificity of human plasma lecithin-cholesterol acyltransferase in the presence of sn-2 arachidonoyl phosphatidyl cholines. Mechanism of formation of saturated cholesteryl esters. Biochim. Biophys. Acta. 1128: 83-92.
29. Fukasawa, M., M. Nishijima, H. Itabe, T. Takano, and K. Hanada. 2000. Reduction of sphingomyelin level without accumulation of ceramide in Chinese hamster ovary cells affects detergent-resistant membrane domains and enhances cellular cholesterol efflux to methyl-beta-cyclodextrin. J. Biol. Chem. 275: 34028-34034.
30. Bligh, E. G., and W. J. Dyer. 1959. A rapid method of total lipid extraction and purification. Can. J. Biochem. Physiol. 37: 911-917.
31. Subbaiah, P. V., J. M. Sowa, and M. H. Davidson. 2004. Evidence for altered positional specificity of LCAT in vivo: studies with docosahexaenoic acid feeding in humans. J. Lipid Res. 45: 2245-2251.
32. Hanasaki, K., K. Yamada, S. Yamamoto, Y. Ishimoto, A. Saiga, T. Ono, M. Ikeda, M. Notoya, S. Kamitani, and H. Arita. 2002. Potent modification of low density lipoprotein by group X secretory phospholipase A(2) is linked to macrophage foam cell formation. J. Biol. Chem. 277: 29116-29124.
33. Slotte, J. P. 1999. Sphingomyelin-cholesterol interactions in biological and model membranes. Chem. Phys. Lipids. 102: 13-27.
34. Ridgway, N. D., T. A. Lagace, H. W. Cook, and D. M. Byers. 1998. Differential effects of sphingomyelin hydrolysis and cholesterol transport on oxysterol-binding protein phosphorylation and Golgi localization. J. Biol. Chem. 273: 31621-31628.
35. Zha, X. H., L. M. Pierini, P. L. Leopold, P. J. Skiba, I. Tabas, and F. R. Maxfield. 1998. Sphingomyelinase treatment induces ATP-independent endocytosis. J. Cell Biol. 140: 39-47.
36. Huang, H. W., E. M. Goldberg, and R. Zidovetzki. 1998. Ceramides perturb the structure of phosphatidylcholine bilayers and modulate the activity of phospholipase A2. Eur. Biophys. J. 27: 361-366.
37. Hashizume, T., K. Kitatani, T. Kageura, M. Hayama, S. Akiba, and T. Sato. 1999. Ceramide enhances susceptibility of membrane phospholipids to phospholipase A(2) through modification of lipid organization in platelet membranes. Biol. Pharm. Bull. 22: 1275-1278.
38. Fanani, M. L., and B. Maggio. 1997. Mutual modulation of sphingomyelinase and phospholipase A2 activities against mixed lipid monolayers by their lipid intermediates and glycosphingolipids. Mol. Membr. Biol. 14: 25-29.
39. 2 and alter its fatty acid specificity. Biochem. J. 363: 45-51.
40. 2. J. Biol. Chem. 279: 11320-11326.
41. Saiga, A., N. Uozumi, T. Ono, K. Seno, Y. Ishimoto, H. Arita, T. Shimizu, and K. Hanasaki. 2005. Group X secretory phospholipase A2 can induce arachidonic acid release and eicosanoid production without activation of cytosolic phospholipase A2 alpha. Prostaglandins Other Lipid Mediat. 75: 79-89.
42. Gulbins, E., and R. Kolesnick. 2003. Raft ceramide in molecular medicine (review). Oncogene. 22: 7070-7077.
43. Balsinde, J., M. A. Balboa, and E. A. Dennis. 1997. Inflammatory activation of arachidonic acid signaling in murine P388D1 macrophages via sphingomyelin synthesis. J. Biol. Chem. 272: 20373-20377.
44. Singer, A. G., F. Ghomashchi, C. Le Calvez, J. Bollinger, S. Bezzine, M. Rouault, M. Sadilek, E. Nguyen, M. Lazdunski, G. Lambeau, et al. 2002. Interfacial kinetic and binding properties of the complete set of human and mouse groups I, II, V, X, and XII secreted phospholipases A2. J. Biol. Chem. 277: 48535-48549.
45. Subbaiah, P. V., and P. H. Pritchard. 1989. Molecular species of phosphatidylcholine in familial lecithin-cholesterol acyltransferase deficiency: effect of enzyme supplementation. Biochim. Biophys. Acta. 1003: 145-150.
46. Ballou, L. R., S. J. Laulederkind, E. F. Rosloniec, and R. Raghow. 1996. Ceramide signalling and the immune response. Biochim. Biophys. Acta. 1301: 273-287.
47. Memon, R. A., W. M. Holleran, A. H. Moser, T. Seki, Y. Uchida, J. Fuller, J. K. Shigenaga, C. Grunfeld, and K. R. Feingold. 1998. Endotoxin and cytokines increase hepatic sphingolipid biosynthesis and produce lipoproteins enriched in ceramides and sphingomyelin. Arterioscler. Thromb. Vasc. Biol. 18: 1257-1265.
48. Ledesma, M. D., B. Brugger, C. Bunning, F. T. Wieland, and C. G. Dotti. 1999. Maturation of the axonal plasma membrane requires upregulation of sphingomyelin synthesis and formation of protein-lipid complexes. EMBO J. 18: 1761-1771.
49. Lightle, S., R. Tosheva, A. Lee, J. Queen-Baker, B. Boyanovsky, S. Shedlofsky, and M. Nikolova-Karakashian. 2003. Elevation of ceramide in serum lipoproteins during acute phase response in humans and mice: role of serine-palmitoyl transferase. Arch. Biochem. Biophys. 419: 120-128.
50. Schissel, S. L., J. Tweedie-Hardman, J. H. Rapp, G. Graham, K. J. Williams, and I. Tabas. 1996. Rabbit aorta and human atherosclerotic lesions hydrolyze the sphingomyelin of retained low-density lipoprotein. Proposed role for arterial-wall sphingomyelinase in subendothelial retention and aggregation of atherogenic lipoproteins. J. Clin. Invest. 98: 1455-1464.
51. Oorni, K., J. K. Hakala, A. Annila, M. Alakorpela, and P. T. Kovanen. 1998. Sphingomyelinase induces aggregation and fusion, but phospholipase A(2) only aggregation, of low density lipoprotein (LDL) particles-two distinct mechanisms leading to increased binding strength of LDL to human aortic proteoglycans. J. Biol. Chem. 273: 29127-29134.
52. Kinnunen, P. K. J., and J. M. Holopainen. 2002. Sphingomyelinase activity of LDL: a link between atherosclerosis, ceramide, and apoptosis? Trends Cardiovasc. Med. 12: 37-42.